Based on ratings from 0 stock analysts, the stock price is expected to decrease by NAN% in 12 months. This is calculated by using the average 12-month stock price forecast for . The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.
BACA is a stock in which has been forecasted to be worth $ as an average. On the higher end, the forecast price is $ by from and on the lower end BACA is forecasted to be $ by from .
These are the latest 20 analyst ratings of BACA.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Data Not Found! |
In 2023, BACA generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BACA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Berenson Acquisition Corp. I (NYSE: BACA) will dissolve and liquidate after failing to complete its business combination by September 30, 2024. Liquidation is set for October 16, 2024.
Why It Matters - Berenson Acquisition Corp. I's failure to complete a business combination and subsequent liquidation may lead to losses for investors, affecting market confidence in SPACs and future fundraising efforts.
Summary - Halper Sadeh LLC is investigating Berenson Acquisition Corp. I (BACA) for potential securities law violations related to its merger with Custom Health Inc., which values Custom Health at $185 million pre-money.
Why It Matters - The investigation into Berenson Acquisition Corp. I's merger with Custom Health raises concerns about potential legal issues, which could impact stock performance and shareholder value.
Summary - Berenson Acquisition Corp. I disclosed an audit opinion highlighting concerns about its ability to continue as a going concern, as noted in its 2023 annual report filed on May 31, 2024.
Why It Matters - The audit opinion raises concerns about Berenson Acquisition Corp.'s financial stability, signaling potential risks to its operations and impacting investor confidence and stock performance.
Summary - Berenson Acquisition Corp. I (NYSE: BACA) received a notice of noncompliance from NYSE for failing to file its 2023 Form 10-K by the deadline. The company aims to regain compliance.
Why It Matters - Noncompliance with NYSE listing standards can lead to delisting, impacting stock liquidity and investor confidence. The company's commitment to regain compliance will be closely monitored.
Summary - Berenson Acquisition Corp. I (NYSE: BACA) will transfer its Class A common stock listing to NYSE American, effective March 13, 2023, while retaining the same ticker symbol.
Why It Matters - The transfer to NYSE American may indicate a shift in the company's market strategy, potentially affecting liquidity, investor perception, and stock volatility.
Summary - Berenson Acquisition Corp. I (NYSE: BACA) canceled its special meeting scheduled for February 7, 2023, and withdrew proposals from its Definitive Proxy Statement filed on November 21, 2022.
Why It Matters - The cancellation of the stockholder meeting and withdrawal of proposals may signal uncertainty or challenges for Berenson Acquisition Corp. I, potentially affecting investor confidence and stock performance.